Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent Health Corp (OP: EMGE )

0.0028 +0.0002 (+7.69%)
Streaming Delayed Price Updated: 3:41 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,742,989
Open 0.0027
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0026
Today's Range 0.0014 - 0.0030
52wk Range 0.0005 - 0.0058
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Resonate Blends Executes a Share Exchange Agreement With Emergent Health Corp.
Via ACCESSWIRE
Emergent Health and Apollo Biowellness Announce Strategic Collaboration
Emergent Health Corp. (OTC: EMGE), a curator, developer, and marketer of products in the Regenerative Health Space announced today that it will be collaborating with Apollo Biowellness, Inc., the... 
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market

Performance

YTD
+211.11%
+211.11%
1 Month
+47.37%
+47.37%
3 Month
+300.00%
+300.00%
6 Month
+300.00%
+300.00%
1 Year
-3.45%
-3.45%

More News

Read More
Emergent Health and Apollo Biowellness Announce Strategic Collaboration
Via News Direct
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies
Via News Direct
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Product Safety Regulatory
Emergent Health Executes Term Sheet and Engagement Letter with Boustead Securities to roll up its Subsidiary, Evolutionary Biologics and other regenerative medicine and products companies
Via TheNewswire.com
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Product Safety Regulatory
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%
Via TheNewswire.com
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Reports Quarter over Quarter Revenue Increase of Over 2300%
Via News Direct
Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Subsidiary Evolutionary Biologics Executes Product Manufacturing Agreement with Major Player in the Regenerative Medicine Space
Via News Direct
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities
Via News Direct
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Subsidiary PharmaZu Retains BF Borgers to Audit its Financial Statement as required by the Engagement Letter with Boustead Securities
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm
Via TheNewswire.com
Topics Initial Public Offering
Exposures Securities Market
Emergent Health to spin out subsidiary PharmaZu to its Shareholders pursuant to an IPO underwritten by a Nationally Recognized Investment Banking Firm
Via News Direct
Topics Initial Public Offering
Exposures Securities Market
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets
Via News Direct
Emergent Health Announces Its Return to the “Pink Current Information” Tier on OTC Markets
Via TheNewswire.com
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100%
Via News Direct
Former L'Oréal President Jim Morrison, Chief Executive Officer of Emergent Health Corp. Reports Year to Year Revenue Increase of Over 380% and Quarter to Quarter Revenue Increase of Over 100%
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Emergent Announces 'Month in Review' with CEO Jim Morrison
Via ACCESSWIRE
Emergent Health Announces Revenue Forecast of $16 Million & Introduces ‘MAXIMUS Men’s Health’
Via ACCESSWIRE
Emergent Health (EMGE) Completes Acquisition of Nanosthetic - Adding $3.5 Million to its Growing Revenue Streams
Via ACCESSWIRE
Emergent Health (EMGE) Executes "Letter of Intent" to Acquire Privately Held Company with a total of $5.4 Million in Current Revenues
Via ACCESSWIRE
(EMGE) Emergent Health Enters Acquisition Talks with Revenue-Producing Medical Company
Via ACCESSWIRE
Emergent Health Announces that Retail Power Hitter and Former Kraft Foods Director of National Accounts, Charlie McMenamin, Plans Product Placements in Nation's Biggest Retail Companies
Via ACCESSWIRE
Emergent Projects $3.5 Million in Revenues With Acquisition of Nanosthetic Corp. Fueling Evolutionary Biologics
Via ACCESSWIRE
Emergent Health Appoints Former Kraft Foods Director of National Accounts Charlie McMenamin to Its Board of Directors
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.